13F Holdings
中文EN

OSRH OSR Health, Inc.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1840425 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-50.4%
TTM net income YoY32.8%
TTM EPS YoY68.1%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin24.3%
Operating margin-946.7%
Net margin-599.0%
FCF margin—
EBITDA margin-944.8%

Returns

ROE-10.2%
ROA-5.6%
ROIC (approx.)-12.9%
Asset turnover0.01x

Leverage & solvency

Liabilities / assets24.5%
Debt / equity0.00x
Current ratio0.15x
Interest coverage-34.95x

Cash quality & payout

Operating cash flow / net income0.48x
Accruals ratio-2.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY2025*2025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$2.91M$3.53M———
Cost of revenue$2.31M$2.72M———
Gross profit$592,905$811,236———
R&D expense$318,446$161,155———
SG&A expense$18.93M$12.50M$1.83M$35,388$3,308
Operating income-$18.34M-$11.69M-$1.83M-$35,388-$3,308
Interest expense$506,196$51,335———
Pretax income-$28.89M-$11.89M$944,591——
Income tax-$1.83M-$1.56M$540,811——
Net income-$18.01M-$2.41M$403,780-$35,388-$3,308
EBITDA-$18.33M-$11.69M———
EPS (basic)-0.92-4.790.05-0.010.00
EPS (diluted)-0.80-4.790.05-0.010.00
Weighted avg. shares (diluted)22.56M2.15M7.72M1.50M1.50M
Balance sheet
Cash & equivalents$1.70M$341,543$540,207$124,501$4,757
Receivables$319,304$904,456———
Inventory$196,432$922,107———
Current assets$2.82M$2.33M$22,627$124,501$4,757
PP&E, net$169,130$2,334———
Goodwill$24.95M$24.35M$27.77M——
Intangibles$142.46M$148.06M———
Total assets$171.24M$175.24M$36.63M$1.23M$705,087
Current liabilities$17.17M$3.46M$2.04M$1.26M$707,207
Short-term debt$0$1.80M$2.02M$1.14M—
Long-term debt$0$497,615———
Total debt$0$2.30M———
Total liabilities$44.20M$32.03M$4.11M$1.26M$707,207
Shareholders' equity$77.64M-$8.33M-$3.91M-$37,508-$2,120
Net debt-$1.70M$1.96M———
Shares outstanding26.60M2.15M2.15M1.73M1.73M
Cash flow statement
Operating cash flow-$4.33M-$1.85M-$818,766-$4,235-$461
Investing cash flow-$2.64M$503,611-$33.83M——
Financing cash flow$8.37M$1.18M$34.54M$123,979-$57,435
Depreciation & amortization$7,269$5,900———
Share buybacks—$36.23M$36.00M——

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.